Nipro Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NPRRF research report →
Price Chart
About the company
Nipro Corporation, along with its various subsidiaries, operates as a diversified global enterprise primarily focusing on three key sectors: medical devices, pharmaceuticals, and pharmaceutical packaging. The company's Medical Device division is responsible for the development, production, and distribution of essential healthcare equipment. This includes products for injection-infusion therapies, dialysis treatments, and solutions for diabetes and cell culture applications, alongside artificial organ-related merchandise.
- CEO
- Yoshihiko Sano
- IPO
- 2018
- Employees
- 36,259
- HQ
- Osaka, JP
Get TickerSpark's AI analysis on NPRRF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.53B
- P/E
- 15.46
- PEG
- 0.11
- P/S
- 0.32
- P/B
- 0.77
- EV/EBITDA
- 7.65
- Div Yield
- 2.33%
- Gross Margin
- 31.71%
- Op Margin
- 5.70%
- Net Margin
- 2.10%
- ROE
- 5.35%
- ROIC
- 2.10%
- 52W High
- $9.96
- 52W Low
- $8.23
- 50D MA
- $9.88
- 200D MA
- $9.52
- Beta
- -0.63
- RSI (14)
- 0
- Avg Volume
- 31
No earnings-call transcripts are available for NPRRF yet.
- Free Float
- 87.0%
- Shares Outstanding
- 163.10M
- Float Shares
- 141.82M
Our NPRRF coverage
Recent articles, reports, and earnings notes.
No research on NPRRF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NPRRF report →